SPONSOR
Keymed Biosciences Co.Ltd
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 2, Phase 2
Conditions studied: Autoimmune CytopeniaImmune Thrombocytopenia (ITP)Autoimmune Hemolytic AnemiaEvans SyndromeAdvanced Solid TumorAtopic DermatitisAtopic Dermatitis (AD)
Keymed Biosciences Co.Ltd is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Autoimmune Cytopenia, Immune Thrombocytopenia (ITP), Autoimmune Hemolytic Anemia, Evans Syndrome.
The trial portfolio spans Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Keymed Biosciences Co.Ltd
How many clinical trials has Keymed Biosciences Co.Ltd sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Keymed Biosciences Co.Ltd, of which 4 are actively recruiting participants. These trials cover conditions including Autoimmune Cytopenia, Immune Thrombocytopenia (ITP), Autoimmune Hemolytic Anemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Keymed Biosciences Co.Ltd research focus on?
Keymed Biosciences Co.Ltd clinical trials span Autoimmune Cytopenia, Immune Thrombocytopenia (ITP), Autoimmune Hemolytic Anemia, Evans Syndrome, Advanced Solid Tumor, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Keymed Biosciences Co.Ltd clinical trial?
To participate in a Keymed Biosciences Co.Ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Keymed Biosciences Co.Ltd trials with current recruitment status updated daily.
Clinical Trials by Keymed Biosciences Co.Ltd
NCT07175493 Phase 1, Phase 2
Recruiting
A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia
Autoimmune Cytopenia
NCT05263960 Phase 1, Phase 2
Recruiting
A Study of CM350 in Patients With Advanced Solid Tumors
Advanced Solid Tumor
NCT06947980 Phase 2
Recruiting
Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis
NCT07230483 Phase 2
Recruiting
A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
Atopic Dermatitis (AD)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology